A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma

Clinical trial NCT00169156 · COMPLETED

Trial details

NCT number: NCT00169156
Sponsor: Lymphoma Study Association
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Untreated T-cell Angioimmunoblastic Lymphoma

Start date: 2005-12-01
Primary completion: 2008-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.